These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2371920)

  • 21. Protective action of vinpocetine against experimentally induced gastric damage in rats.
    Nosálová V; Machová J; Babulová A
    Arzneimittelforschung; 1993 Sep; 43(9):981-5. PubMed ID: 8240463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroprotective and ulcer healing profile of the mast cell stabilizer quazolast in rats.
    Fitzpatrick LR; Decktor DL
    Agents Actions; 1991 Jul; 33(3-4):330-6. PubMed ID: 1683105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oleanolic acid promotes healing of acetic acid-induced chronic gastric lesions in rats.
    Rodríguez JA; Astudillo L; Schmeda-Hirschmann G
    Pharmacol Res; 2003 Sep; 48(3):291-4. PubMed ID: 12860449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and antiulcer activity of N-2-(2-hydroxy-2-phenyl)ethyl-N"-(methanesulfonyl)guanidine analogue of ranitidine. Development of a new antiulcer agent T-593].
    Shibata H; Kusayanagi Y; Arai H; Hashiba K; Yamamoto Y; Onoda M
    Yakugaku Zasshi; 1998 Mar; 118(3):88-104. PubMed ID: 9549432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats.
    Mahattanadul S; Ridtitid W; Nima S; Phdoongsombut N; Ratanasuwon P; Kasiwong S
    J Ethnopharmacol; 2011 Mar; 134(2):243-50. PubMed ID: 21163341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
    Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
    Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
    Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
    Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisecretory and antiulcer activity of Asparagus racemosus Willd. against indomethacin plus phyloric ligation-induced gastric ulcer in rats.
    Bhatnagar M; Sisodia SS
    J Herb Pharmacother; 2006; 6(1):13-20. PubMed ID: 17135157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ulcer effects of 4'-(2-carboxyetyl) phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats.
    Suzuki Y; Hayashi M; Ito M; Yamagami I
    Jpn J Pharmacol; 1976 Aug; 26(4):471-80. PubMed ID: 1003703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An experimental study of the antisecretory and antiulcer activities of kviditen].
    Kaminka ME; Tupikina SM; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(6):36-8. PubMed ID: 7756958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats.
    Yamasaki K; Ishiyama H; Imaizumi T; Kanbe T; Yabuuchi Y
    Jpn J Pharmacol; 1989 Apr; 49(4):441-8. PubMed ID: 2542684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the gastric cytoprotective properties of atropine, ranitidine and PGE2 in rats.
    Del Soldato P; Foschi D; Varin L; Daniotti S
    Eur J Pharmacol; 1984 Oct; 106(1):53-8. PubMed ID: 6099271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MCI-727, a new antiulcer agent, on various gastric and duodenal lesions in experimental animals.
    Yamazaki S; Kawamura M; Kitsukawa M; Ando K; Nitta I; Tobe A; Okabe S
    Jpn J Pharmacol; 1991 Apr; 55(4):415-24. PubMed ID: 1886287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats.
    Wang JY; Nagai H; Okabe S
    Jpn J Pharmacol; 1990 Sep; 54(1):82-5. PubMed ID: 2273651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
    Grant SM; Langtry HD; Brogden RN
    Drugs; 1989 Jun; 37(6):801-70. PubMed ID: 2667937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of carbamate local anesthetics on the occurrence of experimental gastric ulcers.
    Gombosová I; Valentová J; Tumová I; Svec P
    Pharmazie; 1993 Mar; 48(3):212-5. PubMed ID: 8493288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
    Forssell H; Koch G
    Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esculine, ranitidine and carbenoxolone: different modes of action on gastric mucosa.
    Martin MJ; Marhuenda E; Alarcon de la Lastra C
    Gen Pharmacol; 1991; 22(6):1001-4. PubMed ID: 1725772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.